瑞康医药：累计回购公司股份30504859股

Core Viewpoint - Ruikang Pharmaceutical (002589) announced the repurchase of 30,504,859 shares, representing 2.03% of the company's total share capital, through a centralized bidding trading method as of November 4, 2025 [1] Summary by Category - Company Actions - The company has initiated a share repurchase program, accumulating a total of 30,504,859 shares [1] - The repurchased shares account for 2.03% of the current total share capital of the company [1]